Tenax Therapeutics, Inc.
Q1 2025 13F Holders
Symbol
TENX
CUSIP
88032L605
Type
Equity
Class
COM NEW
Num filings
24
Total reported value, excl. options
$13.1 M
Compare 2025 Q1 to
2025 Q2
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type